Pharmarise Holdings Corporation (TYO:2796)
523.00
-1.00 (-0.19%)
Jan 23, 2026, 3:30 PM JST
Pharmarise Holdings Cash Flow Statement
Financials in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '25 Nov 30, 2025 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 | 2016 - 2020 |
Net Income | 342 | 8 | 143 | 1,049 | 1,322 | 1,202 | Upgrade |
Depreciation & Amortization | 1,556 | 1,493 | 1,170 | 1,224 | 1,308 | 1,344 | Upgrade |
Loss (Gain) From Sale of Assets | 205 | 256 | 297 | 396 | 216 | 50 | Upgrade |
Loss (Gain) From Sale of Investments | - | -3 | -19 | - | - | 4 | Upgrade |
Other Operating Activities | -371 | -426 | -990 | -745 | -869 | -610 | Upgrade |
Change in Accounts Receivable | 271 | 392 | 1,437 | 482 | -1,319 | 365 | Upgrade |
Change in Inventory | -895 | -1,091 | -26 | 68 | 286 | 56 | Upgrade |
Change in Accounts Payable | 943 | 910 | 137 | 13 | -500 | -582 | Upgrade |
Change in Other Net Operating Assets | -760 | -228 | 565 | 33 | 269 | 116 | Upgrade |
Operating Cash Flow | 1,291 | 1,311 | 2,714 | 2,520 | 713 | 1,945 | Upgrade |
Operating Cash Flow Growth | 97.40% | -51.70% | 7.70% | 253.44% | -63.34% | 23.73% | Upgrade |
Capital Expenditures | -680 | -637 | -472 | -380 | -379 | -508 | Upgrade |
Sale of Property, Plant & Equipment | 15 | 3 | 16 | 32 | 2 | 41 | Upgrade |
Cash Acquisitions | 10 | -301 | -2,401 | -180 | - | - | Upgrade |
Sale (Purchase) of Intangibles | -47 | -65 | -147 | -162 | -87 | -44 | Upgrade |
Investment in Securities | 30 | 49 | 43 | - | - | 10 | Upgrade |
Other Investing Activities | -3,699 | -3,510 | -47 | -13 | 171 | -569 | Upgrade |
Investing Cash Flow | -4,374 | -4,462 | -3,120 | -703 | -292 | -1,076 | Upgrade |
Long-Term Debt Issued | - | 5,100 | 6,100 | 1,700 | 2,000 | 2,500 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | - | -20 | Upgrade |
Long-Term Debt Repaid | - | -3,716 | -2,586 | -2,419 | -2,636 | -2,857 | Upgrade |
Total Debt Repaid | -2,504 | -3,716 | -2,586 | -2,419 | -2,636 | -2,877 | Upgrade |
Net Debt Issued (Repaid) | -1,404 | 1,384 | 3,514 | -719 | -636 | -377 | Upgrade |
Repurchase of Common Stock | - | - | -340 | - | -2 | -36 | Upgrade |
Common Dividends Paid | -158 | -224 | -127 | -131 | -131 | -129 | Upgrade |
Other Financing Activities | -303 | -221 | -276 | -222 | -265 | -186 | Upgrade |
Financing Cash Flow | -1,865 | 939 | 2,771 | -1,072 | -1,034 | -728 | Upgrade |
Miscellaneous Cash Flow Adjustments | 1 | 3 | 1 | -2 | - | -1 | Upgrade |
Net Cash Flow | -4,947 | -2,209 | 2,366 | 743 | -613 | 140 | Upgrade |
Free Cash Flow | 611 | 674 | 2,242 | 2,140 | 334 | 1,437 | Upgrade |
Free Cash Flow Growth | 281.88% | -69.94% | 4.77% | 540.72% | -76.76% | 17.50% | Upgrade |
Free Cash Flow Margin | 0.92% | 1.06% | 4.12% | 4.11% | 0.65% | 2.75% | Upgrade |
Free Cash Flow Per Share | 53.67 | 59.53 | 213.04 | 171.61 | 26.94 | 116.15 | Upgrade |
Cash Interest Paid | 238 | 191 | 71 | 55 | 66 | 75 | Upgrade |
Cash Income Tax Paid | 413 | 436 | 726 | 836 | 870 | 609 | Upgrade |
Levered Free Cash Flow | 133.88 | 457.13 | 2,824 | 1,975 | 221 | 1,420 | Upgrade |
Unlevered Free Cash Flow | 279.5 | 568.38 | 2,866 | 2,009 | 261.63 | 1,466 | Upgrade |
Change in Working Capital | -441 | -17 | 2,113 | 596 | -1,264 | -45 | Upgrade |
Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.